Dendreon Pharmaceuticals, LLC
Based in CA
🤖
AI Overview
With $2.6M in lobbying spend across 30 quarterly filings, Dendreon Pharmaceuticals, LLC is a significant lobbying presence. Their lobbying covers 3 issue areas. Active from 2019 to 2025.
$2.6M
Total Spend
7
Years Active
1
Firms Hired
1
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $334K |
| 2020 | $480K |
| 2021 | $496K |
| 2022 | $457K |
| 2023 | $416K |
| 2024 | $271K |
| 2025 | $179K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Veterans, MED
- •Medicare Part B Payment Reform
- •Medicare Part B payment reform
- •Clinical pathway for prostate cancer at the VA
- •Access to prostate cancer immunotherapy at the Veterans Health Administration
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.